Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination

NCT01119521 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

82

Enrollment

NIH

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: BCG strain Danish
DRUG: Isoniazid

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)